Total Funding
79
46
Total FundingSeed raised
Growth Score
-9 pts
Heat Score
-5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
43977
Aarvik Therapeutics is a biotechnology company dedicated to engineering precision therapies for oncology targets.
Jagath Reddy Junutula: Co-founder, President & CEO- Sachdev Sidhu: Co-Founder
About the Company
Aarvik Therapeutics combines a unique, proprietary modular platform with multiple target mechanisms to develop novel molecules with an improved therapeutic index for oncology targets. Backed by the extensive scientific research, development, and investment expertise of its founders and Board members, Aarvik Therapeutics is applying its vision and
passion to create transformational benefits for cancer patients.
